Exact Sciences
EXAS
#1383
Rank
HK$102.01 B
Marketcap
HK$552.12
Share price
2.34%
Change (1 day)
-6.67%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of June 2024 : HK$21.52 B

According to Exact Sciences's latest financial reports the company's total debt is HK$21.52 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$19.95 B4.37%
2022-12-31HK$19.11 B2.93%
2021-12-31HK$18.57 B2.79%
2020-12-31HK$18.07 B142.93%
2019-12-31HK$7.43 B37.82%
2018-12-31HK$5.39 B15420.39%
2017-12-31HK$34.77 M-18.36%
2016-12-31HK$42.59 M-8.65%
2015-12-31HK$46.62 M102.07%
2014-12-31HK$23.07 M-31.85%
2013-12-31HK$33.85 M113.7%
2012-12-31HK$15.84 M103.99%
2011-12-31HK$7.76 M-0.18%
2010-12-31HK$7.78 M-49.53%
2009-12-31HK$15.41 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
HK$1.11 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.16 B-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$90.35 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$198.46 B 821.94%๐Ÿ‡ซ๐Ÿ‡ท France